Back
Regenxbio Vs. AbbVie Industry Stock Comparison
Sell
47
RGNX
Regenxbio
Last Price:
15.99
Seasonality Move:
3.1%
Buy
57
ABBV
AbbVie
Last Price:
160.58
Seasonality Move:
-0.31%
Sell
47
Regenxbio (RGNX)
is a Sell
Is Regenxbio a Buy, Sell or Hold?
- The current Regenxbio [RGNX] share price is $16.67. The Score for RGNX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- RGNX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
AbbVie (ABBV)
is a Buy
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $160.45. The Score for ABBV is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- ABBV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RGNX Stock Price Chart
RGNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.7 | Sell |
| Relative Strength Index (14 RSI): | 42.2 | Sell |
| Chaikin Money Flow: | -57891 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.86 - 18.4) | Sell |
| Bollinger Bands (100): | (14.78 - 20.92) | Sell |
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.8 | Sell |
| Relative Strength Index (14 RSI): | 37.5 | Sell |
| Chaikin Money Flow: | -3568781 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (161.62 - 168.34) | Sell |
| Bollinger Bands (100): | (160.19 - 177.23) | Sell |
RGNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.44 | Buy |
| 20-day SMA: | 16.65 | Buy |
| 50-day SMA: | 19.48 | Sell |
| 200-day SMA: | 17.71 | Sell |
| 8-day EMA: | 16.61 | Buy |
| 20-day EMA: | 17.04 | Sell |
| 50-day EMA: | 17.97 | Sell |
| 200-day EMA: | 18.4 | Sell |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 162.03 | Sell |
| 20-day SMA: | 163.88 | Sell |
| 50-day SMA: | 172.06 | Sell |
| 200-day SMA: | 157.76 | Buy |
| 8-day EMA: | 162.41 | Sell |
| 20-day EMA: | 164.8 | Sell |
| 50-day EMA: | 168.08 | Sell |
| 200-day EMA: | 160.82 | Sell |
Regenxbio Earnings Growth & RGNX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.05 per share, an increase this year of $1.00 per share, and an increase next year of $2.51 per share.
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.19 per share, an increase this year of $0.09 per share, and an increase next year of $0.83 per share.
Regenxbio Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AbbVie Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||